Login with your work email address to view charts. No credit card required.
| Art Unit: | 1626 — Drug, bio-affecting and body treating compositions |
|---|---|
| Group: | 1620 — Biomedicinal Chemistry |
| Classes: |
514 — Drug, bio-affecting and body treating compositions 548 — Organic compounds -- part of the class 532-570 series 558 — Organic compounds -- part of the class 532-570 series 544 — Organic compounds -- part of the class 532-570 series 424 — Drug, bio-affecting and body treating compositions 428 — Stock material or miscellaneous articles 549 — Organic compounds -- part of the class 532-570 series 435 — Chemistry: molecular biology and microbiology 546 — Organic compounds -- part of the class 532-570 series 257 — Active solid-state devices (e.g., transistors, solid-state diodes) |
| Phone: | (571) 272-5592 |
| Email: | amanda.aguirre@uspto.gov |
| Title: | Pat Examnr Gen Chem |
| Service: | 14 years |
| Grade: | GS-14 |
| 3-Year Grant rate: | 65% over 464 cases |
|---|---|
| Difficulty: | Harder |
| Difficulty Percentile: | 67th
|
With Examiner Aguirre, you have a 65% chance of getting an issued patent by 3 years after the first office action. Examiner Aguirre is a harder examiner and in the 67th percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Aguirre, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Aguirre's grant rate is lower than that of Art Unit 1626 and lower than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Aguirre | 1.2 |
| Art Unit 1626 | 1.1 |
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.